Company: RGBP
Filing Date: 2025-10-03
Form Type: 8-K
Source: 0001493152-25-016767
Chunk: 2

Company: Regen BioPharma Inc
Filing Date: 2025-10-03
Form: 8-K
Item: Item 8.01
Chunk 2
---
Item
8.01. Other Events

COMMON
SHARES OUTSTANDING:

As
of October3, 2025 Regen Biopharma, Inc. has 79,374,704 common
shares outstanding.

Item
9.01. Financial Statements and Exhibits.

Exhibit
10.1 Lander Agreement

Exhibit
10.2 Koos Agreement

104
Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

                       REGEN                                             
  Dated:               By:                  /s/                          
                       Name:                David                        
                       Title:               Chairman